OptimizeRx

OptimizeRx FCF/Net Income

The Free Cash Flow to Net Income Ratio of OptimizeRx (OPRX) as of Nov 22, 2026 is 363.54 %. In the previous year, Free Cash Flow to Net Income Ratio was -23.75 % — a change of -1,630.42% (higher).

FCF/Net Income

363.54 %

YoY

-1,630.42%

Last updated:

Free Cash Flow to Net Income Ratio of OptimizeRx is 2025 363.54 % . Free Cash Flow to Net Income Ratio of OptimizeRx was 2024 -23.75 % . It decreases by -1,630.42% higher compared to the previous year.

The OptimizeRx FCF/Net Income history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Net Income
Date
FCF/Net Income
Jan 1, 2018
309.95 USD
Jan 1, 2019
103.37 USD
Jan 1, 2020
291.56 USD
Jan 1, 2021
63.49 USD
Jan 1, 2022
-91.00 USD
Jan 1, 2023
46.17 USD
Jan 1, 2024
-23.75 USD
Jan 1, 2025
363.54 USD
The OptimizeRx FCF/Net Income history
YEARFCF/Net IncomeYoY
363.54 %-1,630.42%
-23.75 %-151.44%
46.17 %-150.74%
-91.00 %-243.34%
63.49 %-78.22%
291.56 %+182.05%
103.37 %-66.65%
309.95 %+328.45%
72.34 %+36.54%
52.98 %-176.14%
-69.59 %-253.02%
45.48 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

OptimizeRx Stock analysis

What does OptimizeRx do? The OPTIMIZERx Corporation is an emerging US company that is pursuing a revolutionary approach to solving challenges in healthcare. The company was founded in 2006 and is headquartered in Rochester, Michigan. OPTIMIZERx initially started as a provider of discount incentives to improve medication management. They later developed an innovative E-Prescribing platform to ensure the quick and secure delivery of medications to patients. Their business model focuses on providing scalable platforms and services to simplify and improve patient data management and communication. OPTIMIZERx offers products such as eCoupon, SampleMD, OptimizeRx Digital Therapeutic Support, and OptimizeRx 360. These platforms and services are sold to pharmaceutical companies, doctors, patients, and pharmacies to help reduce costs and optimize business processes. The company is divided into different categories including E-Prescribing, Patient-Centered Support, Point-of-Care Services, and Channel and Content Management. Overall, OPTIMIZERx aims to improve healthcare services through innovative technology and has achieved significant milestones such as a strong customer base and sustainable financial foundation. OptimizeRx is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OptimizeRx stock

Free Cash Flow to Net Income Ratio of OptimizeRx is 363.54 % in 2025.

Free Cash Flow to Net Income Ratio of OptimizeRx changed from -23.75 % to 363.54 %, representing a -1,630.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Net Income Ratio OptimizeRx since 2006 – with annual values, charts, and detailed analysis.

The FCF/Net Income ratio measures cash flow quality. Ratios consistently above 100% suggest high-quality earnings with strong cash backing.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Net Income Ratio's OptimizeRx with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow to Net Income Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow to Net Income Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — OptimizeRx

All Key Metrics — OptimizeRx